These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 1725196

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vascular effects of perindopril: from experimental to clinical investigation.
    Scalbert E, Levy B, Desche P, Devissaguet M, Safar ME.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
    Neutel JM.
    J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of angiotensin converting enzyme inhibition on vascular remodelling of resistance vessels in hypertensive patients.
    Mulvany MJ.
    J Hypertens Suppl; 1996 Dec; 14(6):S21-4. PubMed ID: 9023711
    [Abstract] [Full Text] [Related]

  • 10. Effects of angiotensin-converting enzyme inhibitors on cerebral vascular structure in chronic hypertension.
    Baumbach GL, Chillon JM.
    J Hypertens Suppl; 2000 May; 18(1):S7-11. PubMed ID: 10939784
    [Abstract] [Full Text] [Related]

  • 11. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K, Fujii K, Kansui Y, Iida M.
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
    [Abstract] [Full Text] [Related]

  • 12. The blood vessel as a target organ in hypertension: protective effect of perindopril.
    Plante GE.
    Can J Cardiol; 1994 Nov; 10 Suppl D():25D-29D. PubMed ID: 7954036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vascular remodeling, macro- and microvessels: therapeutic implications.
    Rizzoni D, Muiesan ML, Porteri E, De Ciuceis C, Boari GE, Salvetti M, Paini A, Rosei EA.
    Blood Press; 2009 Nov; 18(5):242-6. PubMed ID: 19919394
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA, Rattan S.
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [Abstract] [Full Text] [Related]

  • 18. Vascular structure, smooth muscle cell phenotype and growth in hypertension.
    Lindop GB, Boyle JJ, McEwan P, Kenyon CJ.
    J Hum Hypertens; 1995 Jun; 9(6):475-8. PubMed ID: 7473530
    [Abstract] [Full Text] [Related]

  • 19. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL.
    Heart Dis; 2000 Jun; 2(5):380-3. PubMed ID: 11728286
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.